±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1440  |  »Ø¸´: 4

ÑîÎÄËÉ˧

ľ³æ (ÕýʽдÊÖ)

[ÇóÖú] Reference StandardÔÚFDAÖÐÊÇʲôÒâ˼£¿¶Ô±ÈRLDÓÐÊ²Ã´Çø±ð ÒÑÓÐ1È˲ÎÓë

FDAÖÐReference StandardºÍReference Listed Drug¸÷ÓÐÊ²Ã´Çø±ð£¿

Reference StandardÔÚFDAÖÐÊÇʲôÒâ˼£¿¶Ô±ÈRLDÓÐÊ²Ã´Çø±ð
U{@U@H2D62L5W}4VFGFMBJS.png
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

Ö»ÊDzÁÉË
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhangxuan200

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÑîÎÄËÉ˧: ½ð±Ò+10, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2017-02-04 16:18:29
A ¡°reference standard¡± is the drug product selected by FDA that an applicant seeking approval of  an ANDA must use in conducting an in vivo bioequivalence study required for approval of the ANDA. To facilitate generic drug development, FDA generally selects a single reference  standard that ANDA applicants must use in any in vivo testing conducted to support a demonstration of bioequivalence. FDA selects a single reference standard to ensure the greatest  level of consistency between a generic drug and its RLD and among generic drugs. Ordinarily,  the reference standard selected by FDA will be the RLD. FDA usually selects as the reference standard the highest strength available for drug products with multiple approved strengths.

reference standardÓ¦¸ÃÊÇ×÷ΪBE±ØÐëÓõIJαÈÖÆ¼ÁµÄÒâ˼£¨Ò»°ãµÄreference standard¾ÍÊÇRLD£©

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

2Â¥2017-02-04 16:07:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÑîÎÄËÉ˧

ľ³æ (ÕýʽдÊÖ)

Ëͺ컨һ¶ä
ÒýÓûØÌû:
2Â¥: Originally posted by zhangxuan200 at 2017-02-04 16:07:55
A ¡°reference standard¡± is the drug product selected by FDA that an applicant seeking approval of  an ANDA must use in conducting an in vivo bioequivalence study required for approval of the ANDA. T ...

лл£¬Ö»ÊÇÎÒ»¹ÊÇÓÐЩ²»Ã÷°×¡£FDAÖиÃÒ©Æ·ÓÐËÄÖÖ¹æ¸ñ£¬²¢ÇÒRLD¾ù±êΪÁËYES£¬ÇÒÖ»ÔÚ×î´ó¼ÁÁ¿µÄ200mgµÄreference standard±êÁËYES£¬ÊDz»ÊÇÆäËûµÄ¹æ¸ñÒ²¿ÉÒÔ×÷Ϊ²Î±ÈÖÆ¼Á£¿
Ö»ÊDzÁÉË
3Â¥2017-02-04 16:23:02
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhangxuan200

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

ÒýÓûØÌû:
3Â¥: Originally posted by ÑîÎÄËÉ˧ at 2017-02-04 16:23:02
лл£¬Ö»ÊÇÎÒ»¹ÊÇÓÐЩ²»Ã÷°×¡£FDAÖиÃÒ©Æ·ÓÐËÄÖÖ¹æ¸ñ£¬²¢ÇÒRLD¾ù±êΪÁËYES£¬ÇÒÖ»ÔÚ×î´ó¼ÁÁ¿µÄ200mgµÄreference standard±êÁËYES£¬ÊDz»ÊÇÆäËûµÄ¹æ¸ñÒ²¿ÉÒÔ×÷Ϊ²Î±ÈÖÆ¼Á£¿...

¼ûÕâ¸öÖ¸µ¼Ô­Ôò£¬¸Õ³öµÄ¡°Referencing Approved Drug Products in ANDA Submissions.¡±
4Â¥2017-02-04 16:41:34
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhangxuan200

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

5Â¥2017-02-04 16:42:41
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÑîÎÄËÉ˧ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤µ÷¼Á +16 kikiki7 2026-03-30 16/800 2026-03-31 10:03 by ÂÈ»¯ÑÇÏõõ£
[Óлú½»Á÷] ¼×»ùÑǻǻÇËáÄÆºÍ¼×»ù»ÇËáõ¥·´Ó¦»úÀí 10+3 kaobao456 2026-03-29 4/200 2026-03-30 23:16 by nBuï®
[¿¼ÑÐ] ÇóÊÕÁô +6 1943443204 2026-03-28 6/300 2026-03-30 20:37 by dick_runner
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³Ì 317Çóµ÷¼Á +7 JKSOIID 2026-03-26 7/350 2026-03-30 20:10 by µÎµÎÉϰ¶Ñ½
[¿¼ÑÐ] 0703»¯Ñ§321·ÖÇóµ÷¼Á +10 Èýdd. 2026-03-30 11/550 2026-03-30 19:24 by markhwc
[¿¼ÑÐ] 322Çóµ÷¼Á£ºÒ»Ö¾Ô¸ºþÄÏ´óѧ ²ÄÁÏÓ뻯¹¤£¨085600£©£¬ÒѹýÁù¼¶¡£ +9 XXСµË 2026-03-29 9/450 2026-03-30 17:18 by limeifeng
[¿¼ÑÐ] 0703»¯Ñ§/290Çóµ÷¼Á/±¾¿Æ¾­Àú·á¸»/¹¤¿ÆÒ²¿É +13 µ¤ÇàÄÌ¸Ç 2026-03-26 15/750 2026-03-30 12:35 by fangnagu
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸ ÄϾ©º½¿Õº½Ìì´óѧ´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶ +6 @taotao 2026-03-26 7/350 2026-03-30 10:43 by ÎÒÊÇС¿µ
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖÐÄÏ´óѧ»¯Ñ§0703×Ü·Ö337Çóµ÷¼Á +6 niko- 2026-03-27 6/300 2026-03-30 10:25 by herarysara
[¿¼ÑÐ] 340Çóµ÷¼Á +6 Amber00 2026-03-26 6/300 2026-03-29 12:06 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] µ÷¼Á¿¼ÑÐ +3 Íõ½ÜÒ» 2026-03-29 3/150 2026-03-29 08:09 by fmesaito
[¿¼ÑÐ] ±¾¿ÆÐÂÄÜÔ´¿ÆÑ§Ó빤³Ì£¬Ò»Ö¾Ô¸»ªÀíÄܶ¯285Çóµ÷¼Á +7 AZMK 2026-03-28 11/550 2026-03-28 21:01 by xxxsssccc
[¿¼ÑÐ] 283Çóµ÷¼Á +3 A child 2026-03-28 3/150 2026-03-28 15:41 by ms629
[¿¼ÑÐ] 394Çóµ÷¼Á +3 ºÃʶàÄ¥¾²ºò¼ÑÒ 2026-03-26 5/250 2026-03-28 14:24 by ÌÆãå¶ù
[¿¼ÑÐ] 283Çóµ÷¼Á +7 A child 2026-03-28 7/350 2026-03-28 12:05 by zllcz
[¿¼ÑÐ] 308Çóµ÷¼Á +7 īīĮ 2026-03-27 7/350 2026-03-28 07:43 by ÈÈÇéɳĮ
[¿¼ÑÐ] 340Çóµ÷¼Á +5 jhx777 2026-03-27 5/250 2026-03-28 04:18 by fmesaito
[¿¼²©] 26É격 +3 ¼ÓÓͳ尡£¡ 2026-03-26 3/150 2026-03-27 15:38 by cls512
[¿¼ÑÐ] »¯Ñ§µ÷¼ÁÒ»Ö¾Ô¸ÉϺ£½»Í¨´óѧ336·Ö-±¾¿ÆÉϺ£211 +4 СÓã°®Óлú 2026-03-25 4/200 2026-03-26 10:19 by aa331100
[¿¼ÑÐ] 340Çóµ÷¼Á +5 »°Ã·ÌÇ111 2026-03-24 5/250 2026-03-25 06:53 by ilovexiaobin
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û